Position in SVTR
Snapshot 2026-10-28- Startup SignalsTop 50%↑72
- Life SciencesTop 50%
- AgentsTop 25%
- Healthcare ServicesTop 50%
About
TJM Labs, founded in 2024 in Delaware, builds AI agents for pharmacies that automate repetitive administrative tasks including prescription entry, data entry, refill management, and patient communication, integrating with existing pharmacy systems via computer vision.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / team· 1
Funding history
- 2026-07-09Series B$75M
Investors · Elephant Partners, Arthur Ventures, Updata PartnersSource · finsmes.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- TJM Labs
AI automation platform for pharmacies, with AI agents handling prescription intake, refills and patient communication.
Series B · $100M · 2026-07
$100M
United States
BusinessLatest roundTotal raisedDate- Assort Health
Uses AI agents to automate patient intake at healthcare providers; covers 22 specialties and has handled more than 125 million patient interactions
Series C · $222M · 2026-06 · Valuation $1.2B
$222MValuation $1.2B - Archy
All-in-one cloud platform for dental practices: scheduling, patient communication, EHR and imaging, insurance verification and claims, billing and payments, and team management in one system, with native AI agents automating insurance, clinical documentation, patient communication and operations, replacing patchworks of legacy on-premise software.
Series C · $97M · 2026-09
$97M - Forus
AI automation of post-prescription healthcare administrative workflows (insurance verification, prior authorization, appeals, patient assistance and pharmacy routing)
Series C · $300M · 2026-09 · Valuation $3.0B
$300MValuation $3.0B
Europe
BusinessLatest roundTotal raisedDate- Tucuvi
Voice AI that automates clinical follow-up and care management workflows
Series A · $184M · 2026-01
$184M - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M - Corti
Uses AI to assess patients in collaboration with clinicians
Series B · $60M · 2023-09
$60M
Other / unspecified
BusinessLatest roundTotal raisedDate- Lumonus AI
Workflow and knowledge management automation for radiation oncology departments (AI Physician)
Series B · $16M · 2025-11
$16M - Revena
Hospital billing automation
Seed · $8M · 2026-02
$8M - Heidi Health
AI ambient documentation and clinical agent for clinicians (AI Care Partner)
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 22 at a nearby stage · 36 in United States
Request intro →Y Combinator
39 Life Sciences deals in the last 24 months · 20 at a nearby stage · 32 in United States
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 14 at a nearby stage · 22 in United States
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in United States
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 12 at a nearby stage · 15 in United States
Request intro →Lightspeed
17 Life Sciences deals in the last 24 months · 11 at a nearby stage · 15 in United States
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.